220 related articles for article (PubMed ID: 15072261)
1. Neurotrophic effects of AMPA.
Limatola C
Cerebellum; 2004; 3(1):2-10. PubMed ID: 15072261
[TBL] [Abstract][Full Text] [Related]
2. Roles of the NMDA Receptor and EAAC1 Transporter in the Modulation of Extracellular Glutamate by Low and High Affinity AMPA Receptors in the Cerebellum in Vivo: Differential Alteration in Chronic Hyperammonemia.
Cabrera-Pastor A; Taoro L; Llansola M; Felipo V
ACS Chem Neurosci; 2015 Dec; 6(12):1913-21. PubMed ID: 26428532
[TBL] [Abstract][Full Text] [Related]
3. α-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid receptor activation protects against phencyclidine-induced caspase-3 activity by activating voltage-gated calcium channels.
Timpe JM; Wang CZ; Kim J; Johnson KM
J Neurosci Res; 2014 Dec; 92(12):1785-91. PubMed ID: 24995437
[TBL] [Abstract][Full Text] [Related]
4. Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors signaling complexes in Bergmann glia.
Millán A; Arias-Montaño JA; Méndez JA; Hernández-Kelly LC; Ortega A
J Neurosci Res; 2004 Oct; 78(1):56-63. PubMed ID: 15372493
[TBL] [Abstract][Full Text] [Related]
5. alpha-Amino-3-hydroxy-5-methyl-4-isoxazole propionate attenuates glutamate-induced caspase-3 cleavage via regulation of glycogen synthase kinase 3beta.
Nishimoto T; Kihara T; Akaike A; Niidome T; Sugimoto H
J Neurosci Res; 2008 Apr; 86(5):1096-105. PubMed ID: 18041091
[TBL] [Abstract][Full Text] [Related]
6. AMPA protects cultured neurons against glutamate excitotoxicity through a phosphatidylinositol 3-kinase-dependent activation in extracellular signal-regulated kinase to upregulate BDNF gene expression.
Wu X; Zhu D; Jiang X; Okagaki P; Mearow K; Zhu G; McCall S; Banaudha K; Lipsky RH; Marini AM
J Neurochem; 2004 Aug; 90(4):807-18. PubMed ID: 15287886
[TBL] [Abstract][Full Text] [Related]
7. Metabotropic glutamate receptor 5 modulates the nitric oxide-cGMP pathway in cerebellum in vivo through activation of AMPA receptors.
Boix J; Llansola M; Cabrera-Pastor A; Felipo V
Neurochem Int; 2011 Apr; 58(5):599-604. PubMed ID: 21300123
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor alpha attenuates the functional expression of AMPA receptors in cortical GABAergic neurons.
Namba H; Nagano T; Iwakura Y; Xiong H; Jourdi H; Takei N; Nawa H
Mol Cell Neurosci; 2006 Apr; 31(4):628-41. PubMed ID: 16443372
[TBL] [Abstract][Full Text] [Related]
9. Is mTOR involved in the mechanisms of the fast-acting antidepressant effects of AMPA receptor agonists?
Hu Y; Liu X; Shen J
Amino Acids; 2013 Mar; 44(3):1093. PubMed ID: 23053021
[No Abstract] [Full Text] [Related]
10. LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease.
Murray TK; Whalley K; Robinson CS; Ward MA; Hicks CA; Lodge D; Vandergriff JL; Baumbarger P; Siuda E; Gates M; Ogden AM; Skolnick P; Zimmerman DM; Nisenbaum ES; Bleakman D; O'Neill MJ
J Pharmacol Exp Ther; 2003 Aug; 306(2):752-62. PubMed ID: 12730350
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of chronic hyperammonemia on modulation of the glutamate-nitric oxide-cGMP pathway by metabotropic glutamate receptor 5 and low and high affinity AMPA receptors in cerebellum in vivo.
Cabrera-Pastor A; Llansola M; Reznikov V; Boix J; Felipo V
Neurochem Int; 2012 Jul; 61(1):63-71. PubMed ID: 22521775
[TBL] [Abstract][Full Text] [Related]
12. AMPA receptor modulation in previously frozen mouse brain sections: opposite effects of calcium in the cortex and hippocampus.
Lapierre L; Valastro B; Miceli D; Massicotte G
Hippocampus; 2000; 10(6):645-53. PubMed ID: 11153710
[TBL] [Abstract][Full Text] [Related]
13. Lead-Induced ERK Activation Is Mediated by GluR2 Non-containing AMPA Receptor in Cortical Neurons.
Ishida K; Kotake Y; Sanoh S; Ohta S
Biol Pharm Bull; 2017; 40(3):303-309. PubMed ID: 28250271
[TBL] [Abstract][Full Text] [Related]
14. Kinetic variability of AMPA receptors among olfactory bulb neurons in culture.
Blakemore LJ; Trombley PQ
Neuroreport; 2003 May; 14(7):965-70. PubMed ID: 12802184
[TBL] [Abstract][Full Text] [Related]
15. IVIG immunotherapy protects against synaptic dysfunction in Alzheimer's disease through complement anaphylatoxin C5a-mediated AMPA-CREB-C/EBP signaling pathway.
Gong B; Pan Y; Zhao W; Knable L; Vempati P; Begum S; Ho L; Wang J; Yemul S; Barnum S; Bilski A; Gong BY; Pasinetti GM
Mol Immunol; 2013 Dec; 56(4):619-29. PubMed ID: 23911420
[TBL] [Abstract][Full Text] [Related]
16. Impaired motor learning attributed to altered AMPA receptor function in the cerebellum of rats with temporal lobe epilepsy: ameliorating effects of Withania somnifera and withanolide A.
Soman S; Anju TR; Jayanarayanan S; Antony S; Paulose CS
Epilepsy Behav; 2013 Jun; 27(3):484-91. PubMed ID: 23602240
[TBL] [Abstract][Full Text] [Related]
17. Presynaptic AMPA receptors: more than just ion channels?
Schenk U; Matteoli M
Biol Cell; 2004 May; 96(4):257-60. PubMed ID: 15145529
[TBL] [Abstract][Full Text] [Related]
18. AMPA, not NMDA, activates RhoA GTPases and subsequently phosphorylates moesin.
Kim SJ; Jeon S; Shin EY; Kim EG; Park J; Bae CD
Exp Mol Med; 2004 Feb; 36(1):98-102. PubMed ID: 15031678
[TBL] [Abstract][Full Text] [Related]
19. Chemical interplay in the mechanism of partial agonist activation in alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
Mankiewicz KA; Rambhadran A; Wathen L; Jayaraman V
Biochemistry; 2008 Jan; 47(1):398-404. PubMed ID: 18081322
[TBL] [Abstract][Full Text] [Related]
20. Microsecond-to-millisecond conformational dynamics demarcate the GluR2 glutamate receptor bound to agonists glutamate, quisqualate, and AMPA.
Valentine ER; Palmer AG
Biochemistry; 2005 Mar; 44(9):3410-7. PubMed ID: 15736951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
